IQVIA AI
AI engineered for life sciences & healthcare
IQVIA Healthcare-grade AI® is engineered to meet the level of precision, speed, and trust required for life sciences and healthcare.
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Safety & Regulatory Compliance
-
Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Global Health
- Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases & Vaccines
- Oncology & Hematology
- Pediatrics
- Rare Diseases
- View All
Obesity
"Advancing obesity and obesity-related trials with patients at the center of development.
LEARN MORE
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWSafety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
REAL WORLD PRODUCTS
- Real World & Healthcare Data
- Health Data Apps & AI
- Analytics Research Accelerator
- Expert Ecosystem
- AI Patient & HCP Profiling- Commercial
- AI Patient & Provider Profiling- Med Affairs
- AI Patient & HCP Profiling- Healthcare
- Natural Language Processing
- Market Access Insights
- Direct-to-Patient Research
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSFEATURED INNOVATIONS
-
IQVIA Connected Intelligence™
-
IQVIA AI
-
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Patient Experience Solutions
WHO WE ARE
- Our Story
- Our Impact
- Commitment to Global Health
- Code of Conduct
- Sustainability
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
IQVIA AI is Healthcare-grade AI®
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA Patient Experience Solutions
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREIQVIA Careers
Featured Careers
Stay Connected
WE'RE HIRING
"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLES
AI designed and guided by experts. Results you can trust.
Everything we do in our industry ultimately has an impact on patients, so it’s imperative that we deliver AI that’s built on a foundation of unparalleled data, expertise, and trust.
With IQVIA Healthcare-grade AI®, we’re building on our rich history of deploying AI to connect the right data, technology, and expertise to address the unique needs of each challenge we help our customers solve.
With IQVIA Healthcare-grade AI®, we’re building on our rich history of deploying AI to connect the right data, technology, and expertise to address the unique needs of each challenge we help our customers solve.
IQVIA AI enables revolutionary patient impact
From diagnosing diseases earlier to finding better ways to treat those diseases, IQVIA Healthcare-grade AI® is helping customers and patients get better results and outcomes.
At IQVIA, we’re committed to advancing patient health all over the world, and we’re excited by the new possibilities AI is creating for the life sciences industry.
At IQVIA, we’re committed to advancing patient health all over the world, and we’re excited by the new possibilities AI is creating for the life sciences industry.
Trust in AI is built on transparency, explainability, auditability, and strong governance. Our solutions meet rigorous scientific and regulatory standards, with experts-in-the-loop to guide development to enable technical soundness and real-world relevance.
IQVIA Healthcare-grade AI® is grounded in quality data, guided by expertise, and connected throughout every IQVIA AI capability. For customers, this enhances time to value, quality of insights, confidence in decision-making, and delivers results at the highest standards.
IQVIA HEALTHCARE-GRADE AI® IN ACTION
Improving patient cutcomes
IQVIA is deploying AI for life sciences companies, governments, and non-profit organizations to power smarter healthcare and get better results, faster.
Closing care gaps with Social Determinants of Health (SDoH)
Challenge: Social factors such as employment status, financial situation, or stress are useful predictors of health outcomes but are often only captured in unstructured physician notes. For example, NorthShore University HealthSystem found only 0.1% of patient records had these fields completed.
Solution: IQVIA assisted NorthShore with the use of Natural Language Processing (NLP) to assess that unstructured data across multiple sources.
Results: NorthShore is now able to help close care gaps by identifying and screening 56% more at-risk patients. In one example, they were able to identify at least one SDoH risk factor in 30% of their patient population (up from only 0.1%).
Solution: IQVIA assisted NorthShore with the use of Natural Language Processing (NLP) to assess that unstructured data across multiple sources.
Results: NorthShore is now able to help close care gaps by identifying and screening 56% more at-risk patients. In one example, they were able to identify at least one SDoH risk factor in 30% of their patient population (up from only 0.1%).
Reducing risk of stroke for AFib patients
Challenge: Atrial Fibrillation (AFib) patients are 5x more likely to have a stroke. IQVIA partnered with the UK National Health Service to reduce AFib related strokes through identifying at-risk patients.
Solution: The risk of stroke for AFib patients was predicted using EMR data including age, gender, and clinical risk factors (e.g. Congestive Heart Failure, Hypertension, Stroke/Transient Ischemic Attack, Diabetes, Vascular Disease).
Results: Annul strokes reduced by approximately 22% during the implementation phase compared to the prior period. This also led to an estimated reduction in healthcare costs amounting to an annual savings of approximately $2m.
Solution: The risk of stroke for AFib patients was predicted using EMR data including age, gender, and clinical risk factors (e.g. Congestive Heart Failure, Hypertension, Stroke/Transient Ischemic Attack, Diabetes, Vascular Disease).
Results: Annul strokes reduced by approximately 22% during the implementation phase compared to the prior period. This also led to an estimated reduction in healthcare costs amounting to an annual savings of approximately $2m.
Improving care for patients with Type 1 Diabetes
Challenge: Nearly 40% of adults with Type 1 Diabetes are initially misdiagnosed with Type 2. IQVIA worked with the Juvenile Diabetes Research Foundation (JDRF) to identify Type 1 patients most likely to be misdiagnosed.
Solution: IQVIA developed an AI algorithm on EMR data, to identify misdiagnosed Type 1 among patients with Type 2 at different points in the patient’s treatment journey.
Results: Inputs into the AI algorithm are routinely collected in EMR data – thus available within any Healthcare Organization (HCO) providing opportunity to deploy the program at scale. The algorithm is currently being prospectively validated at 4 US HCOs testing 2 different scaling paths.
Solution: IQVIA developed an AI algorithm on EMR data, to identify misdiagnosed Type 1 among patients with Type 2 at different points in the patient’s treatment journey.
Results: Inputs into the AI algorithm are routinely collected in EMR data – thus available within any Healthcare Organization (HCO) providing opportunity to deploy the program at scale. The algorithm is currently being prospectively validated at 4 US HCOs testing 2 different scaling paths.
Enhancing routine care for diabetes and CVD
Challenge: The government of one Middle East country is investing in AI to make better healthcare decisions in the diagnosis and treatment of both diabetes and cardiovascular disease.
Solution: IQVIA developed 14 decision support tools that can be used by physicians to help guide screening, improve preventative care and optimise disease management.
Results: The program is being delivered by a cross-functional team of local and global IQVIA experts over a three year period.
Solution: IQVIA developed 14 decision support tools that can be used by physicians to help guide screening, improve preventative care and optimise disease management.
Results: The program is being delivered by a cross-functional team of local and global IQVIA experts over a three year period.
Identifying patients at risk for respiratory disease
Challenge: A client launched a new product to treat respiratory disease. They needed help identifying patient cohorts with this specific unmet need to then reach physicians most likely to have these patients.
Solution: IQVIA deployed the AI/ML Platform capability to identify and profile eligible patient populations with unmet needs. The patients were profiled based on sub-national concentration, demographics and other clinical drivers, with focus on physicians treating them.
Results: Patients predicted for high likelihood to have respiratory disease with 86% precision, while removing approximately 30% of non-target patients from the target population data. Furthermore, a 6-month analysis of patients on this new treatment showed a 17% reduction in uncontrolled disease status.
Solution: IQVIA deployed the AI/ML Platform capability to identify and profile eligible patient populations with unmet needs. The patients were profiled based on sub-national concentration, demographics and other clinical drivers, with focus on physicians treating them.
Results: Patients predicted for high likelihood to have respiratory disease with 86% precision, while removing approximately 30% of non-target patients from the target population data. Furthermore, a 6-month analysis of patients on this new treatment showed a 17% reduction in uncontrolled disease status.
AI GOVERNANCE
Committed to the responsible use of AI
Delivering on the promise of IQVIA Healthcare-grade AI® means applying robust AI governance principles every step of the way, guided by experts-in-the-loop, no matter what kind of AI we’re using.